lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Aptevo Therapeutics
Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth
February 7, 2026
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality
January 9, 2026
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split
December 26, 2025
Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025
December 9, 2025